Delphine Giusti

Centre Hospitalier Universitaire de Reims

Also affiliated with Immuno-Régulation des Maladies Auto- immunes Inflammatoires et Cancer, Université de Reims Champagne-Ardenne

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients”.

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients

British Journal of Dermatology(2023)10.1093/bjd/ljad369

N/A

0DataRank · unranked

44 citations

F. Lombart, G. Chaby, A. Dadban, S. Debarbieux, M. Viguier +28 more